Generated by Meeveem AI
"A global biopharmaceutical company creating solutions for severe neurological and autoimmune disease"
UCB creates valuable biopharmaceutical solutions for people living with severe neurological and autoimmune conditions. The company works closely with diverse networks of patients, caregivers and healthcare professionals to deliver differentiated medicines that improve lives, guided by the belief that everyone deserves to live the best life that they can. UCB's research and development activity across neurology, immunology and other areas of unmet need is driven by connection to the people they serve. Their unique perspectives guide purposeful innovations that create meaningful impact, supported by more than 9,000 people working across nearly 40 countries worldwide since 1928.
9765
Team Members
1928
Founded
Pharma
Sector
Hybrid
Work Environment
A world where everyone living with severe disease can live the best life possible, free from the challenges and uncertainty that disease brings
Creating value in the lives of people living with severe neurological and autoimmune conditions through differentiated solutions